Production (Stage)
Ondine Biomedical Inc.
OBIMF
$0.14
$0.00392.87%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -69.18% | -71.19% | 3.54% | 1.43% | 39.85% |
| Total Depreciation and Amortization | -3.09% | -2.00% | -8.55% | -6.57% | 10.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,695.86% | 1,718.71% | -28.68% | -27.06% | -117.39% |
| Change in Net Operating Assets | 130.97% | 133.69% | 101.69% | 101.73% | -20.64% |
| Cash from Operations | -49.11% | -50.88% | 14.92% | 13.06% | 31.25% |
| Capital Expenditure | 100.00% | 100.00% | 94.29% | 94.25% | 92.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 94.29% | 94.25% | 92.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -242.59% | -242.59% | -6.16% | -6.16% | -89.47% |
| Issuance of Common Stock | 244.48% | 244.48% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -97.29% | -97.29% | -- | -- | -- |
| Cash from Financing | 300.14% | 304.89% | 2,560.00% | 2,612.82% | 3,596.67% |
| Foreign Exchange rate Adjustments | 1,201.43% | 1,216.90% | 131.71% | 132.41% | -91.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 674.24% | 681.07% | 80.02% | 79.58% | 81.12% |